Esclerosis sistémica
| Agente | Año | Tipo de estudio | Pacientes (n) | TR (n) | Casos adversos | Recaída | Muertes |
|---|---|---|---|---|---|---|---|
| INFLIXIMAB | 2003 |
D |
1 |
0 |
1 |
0 |
1 |
2005 |
D |
1 |
1 |
0 |
0 |
0 |
|
2007 |
D |
1 |
1 |
0 |
0 |
0 |
|
2007 |
D |
1 |
1 |
1 |
0 |
0 |
|
| Total | 4 |
3 |
2 |
0 |
1 |
||
| RITUXIMAB | 2005 |
D |
1 |
0 |
0 |
0 |
0 |
2006 |
D |
3 |
3 |
3 |
0 |
1 |
|
| Total | 4 |
3 |
3 |
0 |
1 |
||
| ADALIMUMAB | 2006 |
D |
1 |
0 |
1 |
0 |
1 |
| Total | 1 |
0 |
1 |
0 |
1 |
||
| ETANERCEPT | 2007 |
C |
18 |
15 |
2 |
0 |
0 |
| Total | 18 |
15 |
2 |
0 |
0 |